deltatrials
Unknown NA INTERVENTIONAL 2-arm NCT04194710

Arthroscopic Debridement Versus Autologous Cytokine Rich Serum for the Treatment of Lateral Epicondylitis (DA-SARC)

Randomized Clinical Trial Comparing Arthroscopic Debridement Versus Autologous Cytokine Rich Serum for the Treatment of Lateral Epicondylitis

Sponsor: Corporacion Parc Tauli

Conditions Epicondylitis, Lateral
Interventions Arthroscopic Resection Autologous Cytokine Rich Serum
Updated 5 times since 2020 Last updated: Dec 23, 2020 Started: Dec 22, 2020 Primary completion: Jul 1, 2023 Completion: Dec 1, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04194710, this NA trial focuses on Epicondylitis, Lateral and remains ongoing. Sponsored by Corporacion Parc Tauli, it has been updated 5 times since 2020, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2020 – ~Jan 2021 · 12 months · monthly snapshotRecruiting~Jan 2021 – ~Jan 2024 · 36 months · monthly snapshotRecruiting~Jan 2024 – ~Jul 2024 · 6 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshotUnknown

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Unknown NA

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown NA

    Status: Unknown Status → Unknown

  3. Jan 2024 — Jul 2024 [monthly]

    Unknown Status NA

    Status: Recruiting → Unknown Status

  4. Jan 2021 — Jan 2024 [monthly]

    Recruiting NA

  5. Jan 2020 — Jan 2021 [monthly]

    Recruiting NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Corporacion Parc Tauli
  • Tecnologia Regenerativa Qrem S.L.
Data source: Corporacion Parc Tauli

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations